• Important Safety Information
• Prescribing Information

Alpha₁-antitrypsin (AAT) deficiency* may be one of the most common serious hereditary disorders in the world¹, but it is easily diagnosed, and treatment is available².

About AAT Deficiency Alpha1-antitrypsin (AAT) deficiency is not as rare as previously thought.	Testing and Diagnosis Testing for AAT deficiency can be done with 3 simple blood tests. Our complimentary AlphaTest® Kit makes it is as easy as a finger-stick blood test
Symptoms of AAT Deficiency Early diagnosis is important because, with appropriate therapy and lifestyle modifications, the progression of lung disease may be slowed.	Emphysema and AAT Deficiency Similar clinical presentation contributes to the fact that AAT deficiency is frequently under-recognized
AAT Deficiency eLearning Case Study We created this interactive educational program to help healthcare professionals and others learn more about AAT deficiency. Topics covered include: differentiating factors in symptoms and history, appropriate timing and testing for AATD, and options for effective disease management.

Alpha1Health.com is here to help you manage many aspects of your AAT deficient patients. We invite you to visit other sections of our website to learn more.

Here are some good starting points:

ARALAST [Alpha₁-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A₁-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A₁-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information

1. de Serres, F.J., Worldwide Racial and Ethnic Distribution of α₁-Antitrypsin Deficiency: Summary of an Analysis of Published Genetic Epidemiologic Surveys. CHEST. 2002;122:1828.
2. American Thoracic Society /European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003; 168:834-837.